Navigation Links
PDI Reports 2011 Fourth Quarter and Year End Financial Results
Date:3/7/2012

quivalents were predominantly invested in U.S. Treasury money market funds and the company had no commercial debt.

2012 OutlookThe company's outlook for 2012 is based on current and expected market conditions which are heavily influenced by the assumptions of: 1) increasing and sustained long-term growth of the CSO industry; 2) PDI's ability to continue to win an increasing amount of new business and/or expand its existing business; and 3) tight control of ongoing expenses while investing in the expansion of PDI's capabilities, among others.

As discussed, the company's pipeline of new business is at a three-year high. However, due to industry dynamics, the awarding of contracts in the pipeline has slowed. Given the uncertainty of the timing of contract awards, the company cannot give specific annual revenue guidance. However, for the full year of 2012 the company expects to achieve profitability from continuing operations at the operating income level, with positive Adjusted EBITDA.

Non-GAAP Financial MeasuresIn addition to the United States generally accepted accounting principles, or GAAP, results provided throughout this document, PDI has provided certain non-GAAP financial measures to help evaluate the results of its performance. These non-GAAP financial measures are related to the impact of the Group DCA operating results and the buy-out of certain potential earn-out provisions of the Group DCA purchase agreement. The company believes that these non-GAAP financial measures, when presented in conjunction with comparable GAAP financial measures, are useful to both management and investors in analyzing the company's ongoing business and operating performance. The company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the company's financial results in the way that management views financial results. A table included with this press release includes a rec
'/>"/>

SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results
2. Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
3. Stereotaxis Reports 2011 Financial Results; Provides 2012 Milestones
4. ZONARE Reports Fourth Quarter and 2011 Results
5. IRIDEX Reports 2011 Fourth Quarter and Year-End Results
6. Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
7. Nektar Therapeutics Reports Fourth Quarter and Year-End 2011 Financial Results
8. Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results
9. ERT Reports Fourth Quarter and Full Year 2011 Operating Results
10. Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
(Date:5/6/2015)... May 05, 2015 Research and Markets ... of the "Chromatography (Instruments and Reagents) Global ... their offering. Chromatography is an analytical ... component of a complex mixture by differential movement ... the scientists have considered chromatography as an esoteric ...
(Date:5/6/2015)... 2015   CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... treatment at the EUROHEADPAIN - Midterm Meeting at the ... , from May 14-17, 2015. On ... a major European research project focused on migraines, ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... NEW YORK, April 21, 2011 Amgen (NASDAQ: ... and provided financial guidance for 2015 during a meeting with ... CEO opened the meeting by outlining key elements of the ... advance treatment of serious illness; Make significant and ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 2Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 3Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 4Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 5Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 6Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 7Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans 8
(Date:5/6/2015)... (PRWEB) May 07, 2015 New ... NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May 27, 2015 — ... , Most drugs contain 70-90% excipients, which ... agents or other purposes that facilitate the manufacturing ... the pharma industry, combined with a regulatory focus ...
(Date:5/6/2015)... RPS Revolution - a game for the ... true Rock Paper Scissors game - is now taking ... storytelling and easy to learn rules from Rock Paper Scissors, ... favorite. RPS Revolution takes the best parts of ... are grouped in set of three called Trios. Trios like ...
(Date:5/6/2015)... May 06, 2015 As Hilo ... HIMSS EMR Adoption Model, the hospital looked for ... engagement and automate processes. The leadership team realized ... to electronic workflows, patient registration still required patients ... consents. With HIMSS Stage 7 attestation fast approaching, ...
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... The Beryl Institute announces the publication ... Experience Journal (PXJ), an international, open access, peer-reviewed journal ... improving patient experience. The second volume of PXJ supports ... helps align the voices engaged and provides the space ... association with The Beryl Institute, Volume 2, Issue 1 ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2
... therapy of Prostacyclin, Sildenafil, and Bosentan helped a ... enough to receive a liver transplant. It was ... health. These findings are published in the March ... Wiley & Sons. The article is also available ...
... between two closely related strains of the influenza A ... flu epidemics, according to biologists. The findings could help ... lead to seasonal epidemics., Until now, it was believed that ... with influenza viruses that infect birds causes severe ...
... WASHINGTON, March 4 Enrollment in,Consumer-Directed Health Plans ... health care information tools to employees in order,to ... to a study,commissioned by the American Association of ... Inc., (Logo: http://www.newscom.com/cgi-bin/prnh/20060126/CLTH062LOGO ), ...
... BlueCross BlueShield of South,Carolina announced today that the second ... lunchtime hours on Wednesday, April 30, 2008., Blue ... well as,other employers, will encourage their employees to wear ... a 30-minute lunchtime walk., The motivation behind National ...
... launch of the latest fleet golf car and the ... Inc., a leader in,manufacturing execution systems (MES) for the ... online event,titled "Launching the E-Z-GO Fleet Golf Car: Integrating ... will,take place on Thursday, March 6, 2008 at 2:00 ...
... heighten accuracy with Microsoft Dynamics ... ... that AliMed, a producer and catalog-based distributor of medical,products, has chosen ... its business and expanding its interaction with,customers. The technology will enable ...
Cached Medicine News:Health News:A combination therapy of 3 vasodilators may treat portopulmonary hypertension 2Health News:Study uncovers cause of flu epidemics 2Health News:Study uncovers cause of flu epidemics 3Health News:Consumer-Directed Health Plans Continue to Grow as Popular Vehicle to Bring Choice, Flexibility and Access to Consumers 2Health News:Consumer-Directed Health Plans Continue to Grow as Popular Vehicle to Bring Choice, Flexibility and Access to Consumers 3Health News:S.C. BlueCross Announces Second Annual National Walk @ Lunch Day 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 2Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 4Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 5
... The Equalizer With 384 Well Plate Capability ... revolutionary features of the original Equalizerexpandable and equal ... components, and in-lab calibration capabilities. In addition, this ... down to 4.5mm for loading and accessing many ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
... transfer samples from 96-well plates ... Accurately deliver 0.5-5 μl. Complete ... six minutes or less. Compatible ... and other gels with microwell ...
... Equally Spaced, Expandable, Multichannel Pipettor ... pipettors and instantly boosts productivity with an ... the simple adjustment of a slide rod. ... transfer of liquids between vessels with different ...
Medicine Products: